Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Revive Therapeutics Ltd (RVVTF)

Revive Therapeutics Ltd (RVVTF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study

TORONTO, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research...

RVV.CN : 0.0150 (+50.00%)
RVVTF : 0.0110 (unch)
Revive Therapeutics Announces Closing of Second Tranche of Private Placement

TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing...

RVV.CN : 0.0150 (+50.00%)
RVVTF : 0.0110 (unch)
Revive Therapeutics Announces Extension of Proposed Private Placement

TORONTO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing...

RVV.CN : 0.0150 (+50.00%)
RVVTF : 0.0110 (unch)
Revive Therapeutics Announces Closing of First Tranche of Private Placement and Debt Settlement

TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“ Revive ” or the “ Company ”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to...

RVV.CN : 0.0150 (+50.00%)
RVVTF : 0.0110 (unch)
Revive Therapeutics Announces Proposed Private Placement and Debt Settlement

TORONTO, July 30, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing...

RVV.CN : 0.0150 (+50.00%)
RVVTF : 0.0110 (unch)
Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study

RVV.CN : 0.0150 (+50.00%)
RVVTF : 0.0110 (unch)
Revive Therapeutics Nears Completion of Key Nerve Agent Countermeasure Study with Canadian Department of National Defence Highlighting Significant Stockpiling Opportunity

RVV.CN : 0.0150 (+50.00%)
RVVTF : 0.0110 (unch)
Revive Therapeutics Advances with Next-Generation Bucillamine Development

RVV.CN : 0.0150 (+50.00%)
RVVTF : 0.0110 (unch)
Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure

RVV.CN : 0.0150 (+50.00%)
RVVTF : 0.0110 (unch)
Revive Therapeutics Announces Proposed Shares for Debt Transaction

RVV.CN : 0.0150 (+50.00%)
RVVTF : 0.0110 (unch)

Barchart Exclusives

Nvidia Just Gave Its CUDA Platform a Major Revamp. Will That Move the Needle for NVDA Stock?
Nvidia just updated its CUDA platform and made it a lot more attractive for developers. Is this a game-changer for NVDA stock? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar